Evidence map›Paper›PMID 28614669›Full record

ArticleAmerican journal of respiratory and critical care medicine2017

Severe Pneumococcal Pneumonia Causes Acute Cardiac Toxicity and Subsequent Cardiac Remodeling.

Luis F Reyes, Marcos I Restrepo, Cecilia A Hinojosa, Nilam J Soni, Antonio Anzueto, Bettina L Babu, Norberto Gonzalez-Juarbe, Alejandro H Rodriguez, Alejandro Jimenez, James D Chalmers and 11 more

Open access · greenAbstract read
In one paragraph

Article in American journal of respiratory and critical care medicine, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 78 papers.

0numbers the graph read from it
0cells of the map it votes in
78citing papers in PubMed
10.9field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

78 citing papers in PubMed, 148 citations in OpenAlex.

  1. Trial
  2. Review
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Review
  18. Immune mediators in heart-lung communication.Pflugers Archiv : European journal of physiology · 2025
    Review
  19. Review
  20. Observational

18 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

21 authors at 11 institutions in 6 countries.

Luis F Reyes1 Division of Pulmonary Diseases and Critical Care Medicine.ORCID 0000-0003-1172-6539
Marcos I Restrepo1 Division of Pulmonary Diseases and Critical Care Medicine.ORCID 0000-0001-9107-3405
Cecilia A Hinojosa1 Division of Pulmonary Diseases and Critical Care Medicine.
Nilam J Soni1 Division of Pulmonary Diseases and Critical Care Medicine.
Antonio Anzueto1 Division of Pulmonary Diseases and Critical Care Medicine.
Bettina L Babu1 Division of Pulmonary Diseases and Critical Care Medicine.
Norberto Gonzalez-Juarbe3 Department of Microbiology, The University of Alabama at Birmingham School of Medicine, Birmingham, Alabama.
Alejandro H Rodriguez4 Critical Care Medicine, Hospital Universitari de Tarragona Joan XXIII, Rovira i Virgili University, Tarragona, Spain.
Alejandro Jimenez6 Cardiovascular Medicine, Heart & Vascular Institute, Cleveland Clinic, Abu Dhabi, United Arab Emirates.
James D Chalmers7 School of Medicine, University of Dundee, Dundee, United Kingdom.
Stefano Aliberti8 Department of Pathophysiology and Transplantation, University of Milan, Milan, Italy.
Oriol Sibila11 Division of Pulmonary Diseases, Department of Medicine, Hospital de la Santa Creu i Sant Pau, Autonomous University of Barcelona, Barcelona, Spain.
Vicki T Winter12 Department of Pathology, and.
Jacqueline J Coalson12 Department of Pathology, and.
Luis D Giavedoni13 Texas Biomedical Research Institute, San Antonio, Texas.
Charles S Dela Cruz14 Division of Pulmonary and Critical Care Medicine, Yale University, New Haven, Connecticut.
Grant W Waterer15 Royal Perth Hospital Unit, University of Western Australia, Perth, Australia; and.
Martin Witzenrath16 Department of Infectious Diseases and Pulmonary Medicine and.
Norbert Suttorp16 Department of Infectious Diseases and Pulmonary Medicine and.
Peter H Dube18 Department of Immunology and Microbiology, The University of Texas Health Science Center at San Antonio, San Antonio, Texas.
Carlos J Orihuela3 Department of Microbiology, The University of Alabama at Birmingham School of Medicine, Birmingham, Alabama.
South Texas Veterans Health Care System · USCharité - Universitätsmedizin Berlin · DEUniversity of Alabama at Birmingham · USCentre for Biomedical Network Research on Rare Diseases · ESTexas Biomedical Research Institute · USThe University of Texas Health Science Center at San Antonio · USThe University of Western Australia · AUUniversitat Autònoma de Barcelona · ESUniversity of Dundee · GBUniversity of Milan · ITYale University · US

Funding

The Southwest National Primate Research Center Supplement- Infrastructure improvements of ABSL2 holding areasP51OD011133 · OD · TEXAS BIOMEDICAL RESEARCH INSTITUTE · PI Larry S. Schlesinger · 2012 to 2026
$129.7M
Yale Clinical and Translational Science Award (U Component)UL1TR001863 · NCATS · YALE UNIVERSITY · PI John H. Krystal, LUCILA OHNO-MACHADO · 2016 to 2026
$102.9M
IMMUNOLOGIC DISEASES AND BASIC IMMUNOLOGYT32AI007051 · NIAID · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI Laurie Ellen Harrington · 1985 to 2026
$13.1M
Mentored Experiences in Research, Instruction and Teaching (MERIT) Program - administrative supplementK12GM088010 · NIGMS · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI SCHNEIDER, DAVID ALAN · 2009 to 2024
$9.2M
Cardiac microlesion formation during invasive pneumococcal diseaseR01AI114800 · NIAID · UNIVERSITY OF TEXAS HLTH SCIENCE CENTER · PI Carlos J Orihuela, Herve S TETTELIN · 2015 to 2026
$5.1M
Host-Pneumococcal Interaction in the LungR01HL126094 · NHLBI · YALE UNIVERSITY · PI DELA CRUZ, CHARLES S · 2015 to 2019
$2.1M
Effect of macrolides as immunomodulators in patients with sepsis and pneumoniaK23HL096054 · NHLBI · UNIVERSITY OF TEXAS HLTH SCIENCE CENTER · PI RESTREPO, MARCOS I. · 2010 to 2014
$689k
NCATS NIH HHS UL1 TR001863NHLBI NIH HHS K23 HL096054NHLBI NIH HHS R01 HL126094NIAID NIH HHS R01 AI114800NIAID NIH HHS T32 AI007051NIGMS NIH HHS K12 GM088010NIH HHS P51 OD011133
6 · The paper itself

Abstract

rationaleUp to one-third of patients hospitalized with pneumococcal pneumonia experience major adverse cardiac events (MACE) during or after pneumonia. In mice, Streptococcus pneumoniae can invade the myocardium, induce cardiomyocyte death, and disrupt cardiac function following bacteremia, but it is unknown whether the same occurs in humans with severe pneumonia.

objectivesWe sought to determine whether S. pneumoniae can (1) translocate the heart, (2) induce cardiomyocyte death, (3) cause MACE, and (4) induce cardiac scar formation after antibiotic treatment during severe pneumonia using a nonhuman primate (NHP) model.

methodsWe examined cardiac tissue from six adult NHPs with severe pneumococcal pneumonia and three uninfected control animals. Three animals were rescued with antibiotics (convalescent animals). Electrocardiographic, echocardiographic, and serum biomarkers of cardiac damage were measured (troponin T, N-terminal pro-brain natriuretic peptide, and heart-type fatty acid binding protein). Histological examination included hematoxylin and eosin staining, immunofluorescence, immunohistochemistry, picrosirius red staining, and transmission electron microscopy. Immunoblots were used to assess the underlying mechanisms. MEASUREMENTS AND MAIN

resultsNonspecific ischemic alterations were detected by electrocardiography and echocardiography. Serum levels of troponin T and heart-type fatty acid binding protein were increased (P < 0.05) after pneumococcal infection in both acutely ill and convalescent NHPs. S. pneumoniae was detected in the myocardium of all NHPs with acute severe pneumonia. Necroptosis and apoptosis were detected in the myocardium of both acutely ill and convalescent NHPs. Evidence of cardiac scar formation was observed only in convalescent animals by transmission electron microscopy and picrosirius red staining.

conclusionsS. pneumoniae invades the myocardium and induces cardiac injury with necroptosis and apoptosis, followed by cardiac scarring after antibiotic therapy, in an NHP model of severe pneumonia.

Indexed as

AnimalsAnti-Bacterial AgentsBlotting, WesternCardiotoxicityDisease Models, AnimalEchocardiographyElectrocardiographyFatty Acid-Binding ProteinsFemaleHeartMaleMyocardiumPapioPneumonia, PneumococcalStreptococcus pneumoniaeTroponin TAnti-Bacterial AgentsFatty Acid-Binding ProteinsTroponin Tcardiovascular complicationscommunity-acquired pneumoniapneumococcal pneumoniaStreptococcus pneumoniae

Identifiers

PMID28614669
PMCPMC5620668
OpenAlexW2729235069

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.